Peripheral Artery Disease (PAD)

This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia. 

Feature | Dave Fornell

There have been several key news items from the U.S. stent market over the past year. These include the introduction of ...

Home September 26, 2011
Home
Technology

September 20, 2011 — Boston Scientific Corp. has launched its Coyote Balloon Catheter, a highly deliverable and ultra ...

Home September 20, 2011
Home
News

September 15, 2011 — Very positive results were reported in the first account of a clinical study evaluating the ...

Home September 15, 2011
Home
News

September 13, 2011 – An U.S. Food and Drug Administration’s (FDA) will discuss recommendations for Cook Medical Zilver ...

Home September 13, 2011
Home
News

September 8, 2011 – Abbott announced the initiation of ABSORB BTK, an international clinical trial evaluating the safety ...

Home September 08, 2011
Home
News

September 1, 2011 ­– Medrad Inc. has acquired Pathway Medical Technologies Inc. to strength its vascular interventional ...

Home September 01, 2011
Home
News

August 29, 2011 — The Guidelines on Peripheral Artery Disease (PAD) are the first document produced by the European ...

Home August 29, 2011
Home
News

August 25, 2011 – Two articles in the Society of Interventional Radiology (SIR)'s flagship publication, the Journal of ...

Home August 25, 2011
Home
News

August 25, 2011 – ­ The Munich biotech company apceth started its first Phase I/II clinical study on somatic cell ...

Home August 25, 2011
Home
News

August 10, 2011 – The U.S. Food and Drug Administration (FDA) has approved Abbott’s RX Herculink Elite Renal Stent ...

Home August 10, 2011
Home
News

August 5, 2011 — BridgePoint Medical Inc., a Minnesota-based medical device company, has enrolled its first patient in ...

Home August 05, 2011
Home
News

August 5, 2011 — Vessix Vascular Inc. (formerly known as Minnow Medical Inc.), developer of novel percutaneous ...

Home August 05, 2011
Home
Technology

August 2, 2011 – The U.S. Food and Drug Administration said it recently cleared Abbott Vascular’s RX Herculink Elite ...

Home August 02, 2011
Home
News

July 20, 2011 — IDEV Technologies Inc. announced the completion of enrollment in the SUPERB trial, a U.S. Food and Drug ...

Home July 20, 2011
Home
News

July 18, 2011 — NSVascular Inc., a newly formed subsidiary of NeuroSigma Inc., has signed an exclusive license with the ...

Home July 18, 2011
Home
Subscribe Now